ER–/PR+ Breast Cancer Is Controlled More Effectively with an Inflammatory Inhibitor than Hormonal Inhibitor

By
Laurisa Dohm
-
0
214
In in vitro and ex vivo 3D organoid models, inflammation inhibitor-specific blocked ER–/PR+ tumor proliferation and migration.
[Breast Cancer]
Abstract